Medicine and Dentistry
Amino Terminal Sequence
50%
Anticancer Drug
50%
B Cell
50%
Bacillus Thuringiensis
100%
Carboxy Terminal Sequence
50%
Cell Membrane
50%
Conjugate
100%
Cytolysis
50%
Epitope
50%
Hybridoma
50%
Immunoglobulin M
50%
M Protein
100%
Malignant Neoplasm
50%
Multiple Myeloma
100%
Myelin Basic Protein
100%
Myeloma Cell
100%
Resistant Cell Line
50%
Ricin A
50%
Shuttle Vector
50%
Target Cell
50%
Immunology and Microbiology
Amino Terminal Sequence
50%
B Cell
50%
Bacillus Thuringiensis
100%
Blood Plasma
50%
Carboxy Terminal Sequence
50%
Cell Membrane
50%
Conjugate
100%
Cytolysis
50%
Epitope
50%
Hybridoma
50%
Immunoglobulin M
50%
Multiple Myeloma
100%
Myelin
100%
Myeloma Cell
100%
Resistant Cell Line
50%
Ricin A
50%
Shuttle Vector
50%
Target Cell
50%
Keyphrases
Amino-terminus
20%
Anticancer Agents
20%
B.thuringiensis
20%
Bacillus Thuringiensis
100%
Carboxyl Terminus
20%
Cell Membrane
20%
Cyt1Aa
100%
Cytolysis
20%
Encoding Gene
20%
Epitope
20%
Hybridoma Cells
20%
Immunoglobulin M
20%
Incurable Cancer
20%
Israelensis
100%
M Protein
40%
Multiple Myeloma
40%
Myelin Basic Protein
40%
Myeloma Cells
100%
Overproduction
20%
Patient-specific
20%
Peptidic
20%
Plasma B Cell
20%
Recombinant
20%
Recombinant Fusion
20%
Resistant Cell Lines
20%
Ricin
20%
Shuttle Vector
20%
Specific Targeting
100%
Pharmacology, Toxicology and Pharmaceutical Science
Anticancer Drug
50%
Bacillus Thuringiensis
100%
Epitope
50%
Immunoglobulin M
50%
M Protein
100%
Malignant Neoplasm
50%
Multiple Myeloma
100%
Myelin Basic Protein
100%
Myeloma
100%
Ricin A
50%